Sign in
RGC Stock Price, Chart, Stats & News
Regencell Bioscience Holdings Limited
Save
Regencell Bioscience Holdings Limited (RGC) does not currently pay a dividend.
3.08B
Market cap
–
Current P/E
–
Forward P/E
RGC chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -62.27% |
ROE | -61.93% |
D/E | 0.11x |
Interest coverage ratio | – |
RGC valuation
P/E | – |
P/S | – |
P/B | 2611.69x |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | -35.42x |
EV multiple | -3619.22x |
About
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).
Similar securities
Based on sector and market capitalization
Report issue